SK BIOSCIENCE SEEKS VACCINE APPROVAL
입력 2022.08.11 (15:13)
수정 2022.08.11 (16:45)
읽어주기 기능은 크롬기반의
브라우저에서만 사용하실 수 있습니다.
[Anchor Lead]
SK Bioscience plans to submit an application for government approval of its COVID-19 vaccine SKYCovione next week. The pharmaceutical expects that the vaccine will hit the domestic market later this month. As the nation's first home-grown COVID-19 vaccine, SKYCovione won conditional approval from the Ministry of Food and Drug Safety. In March, SK Bioscience signed a contract with the Korea Disease Control and Prevention Agency to supply ten million doses of the vaccine for domestic use.
SK Bioscience plans to submit an application for government approval of its COVID-19 vaccine SKYCovione next week. The pharmaceutical expects that the vaccine will hit the domestic market later this month. As the nation's first home-grown COVID-19 vaccine, SKYCovione won conditional approval from the Ministry of Food and Drug Safety. In March, SK Bioscience signed a contract with the Korea Disease Control and Prevention Agency to supply ten million doses of the vaccine for domestic use.
■ 제보하기
▷ 카카오톡 : 'KBS제보' 검색, 채널 추가
▷ 전화 : 02-781-1234, 4444
▷ 이메일 : kbs1234@kbs.co.kr
▷ 유튜브, 네이버, 카카오에서도 KBS뉴스를 구독해주세요!
- SK BIOSCIENCE SEEKS VACCINE APPROVAL
-
- 입력 2022-08-11 15:13:32
- 수정2022-08-11 16:45:06
[Anchor Lead]
SK Bioscience plans to submit an application for government approval of its COVID-19 vaccine SKYCovione next week. The pharmaceutical expects that the vaccine will hit the domestic market later this month. As the nation's first home-grown COVID-19 vaccine, SKYCovione won conditional approval from the Ministry of Food and Drug Safety. In March, SK Bioscience signed a contract with the Korea Disease Control and Prevention Agency to supply ten million doses of the vaccine for domestic use.
SK Bioscience plans to submit an application for government approval of its COVID-19 vaccine SKYCovione next week. The pharmaceutical expects that the vaccine will hit the domestic market later this month. As the nation's first home-grown COVID-19 vaccine, SKYCovione won conditional approval from the Ministry of Food and Drug Safety. In March, SK Bioscience signed a contract with the Korea Disease Control and Prevention Agency to supply ten million doses of the vaccine for domestic use.
이 기사가 좋으셨다면
-
좋아요
0
-
응원해요
0
-
후속 원해요
0
오늘의 핫 클릭
실시간 뜨거운 관심을 받고 있는 뉴스
헤드라인
![[단독] 윤석열 정부, ‘대통령실 공사비 미지급’ 피소](/data/news/2025/06/30/20250630_8MRvHk.png)
이 기사에 대한 의견을 남겨주세요.